Related Experiment Video
Updated: Aug 21, 2026

Electromagnetic Source Imaging in Presurgical Evaluation of Children with Drug-Resistant Epilepsy
Published on: September 20, 2024
Valproic acid-induced pancreatitis in childhood epilepsy: case series and review
D Barry Sinclair1, Marjorie Berg, Rene Breault
1Division of Pediatric Neurology, 2C3 Walter MacKenzie Health Sciences Centre, University of Alberta, Edmonton, AB T6G 2R7, Canada. bsinclai@cha.ab.ca
Insights
Valproic acid can cause pancreatitis in children, a severe side effect. Early detection through lipase levels is crucial, especially in those with a history of drug sensitivity.
Area of Science:
- Pediatric Neurology
- Clinical Pharmacology
- Gastroenterology
Background:
- Valproic acid is a widely used anticonvulsant for pediatric epilepsy.
- Pancreatitis is a rare but serious adverse effect associated with valproic acid.
- Previous literature primarily consists of isolated case reports of valproic acid-induced pancreatitis.
Observation:
- Eleven pediatric cases of pancreatitis linked to valproic acid were identified over six years.
- Patients presented with either acute abdominal pain (8/11) or flu-like symptoms (3/11).
- Serum lipase levels were significantly elevated, ranging from 341 to 5576 U/L.
Findings:
- No correlation was found between valproic acid dosage, serum levels, duration of therapy, or concomitant medications and pancreatitis risk.
- Children with a history of drug allergies, particularly skin rashes, may be at increased risk.
- Reintroduction of valproic acid in one patient led to a second pancreatitis episode, confirming causality.
Implications:
- Pancreatitis is a significant adverse event in pediatric valproic acid users.
- Monitoring serum lipase levels is recommended for children on valproic acid presenting with abdominal or flu-like symptoms.
- Children with known drug sensitivities may warrant closer monitoring for pancreatitis during valproic acid therapy.
Abstract:
In the past 6 years, 11 children on valproic acid have developed pancreatitis in our children's hospital. Valproic acid has been used as one of the primary anticonvulsants for generalized seizures in children for the past 25 years. A literature review reveals mostly singular reports of pancreatitis over the past decade. The charts of the 11 patients with valproic acid-induced pancreatitis were reviewed. Dosage, valproic acid serum levels, duration of therapy, and concomitant medications were examined. Families were contacted by telephone to determine the formulation (brand name vs generic) of valproic acid at the time of diagnosis. Six girls and five boys were studied. The ages ranged from 4 to 16 years. Eight of 11 children presented with an acute abdomen. Unexpectedly, three children presented with a flulike illness. Serum lipase values ranged from 341 to 5576 U/L (normal range < 190 U/L). The dose of valproic acid ranged from 20 to 50 mg/kg. Serum levels ranged from 334 to 884 micromol/L (therapeutic range 350-800 micromol/L). Six of the patients were on monotherapy. Seven children were on brand-name drugs. Four of the children had an abnormal neurologic syndromic diagnosis (West syndrome, Rett syndrome, Lowe syndrome, and Angelman's syndrome). Six of the children had a history of drug allergies with a skin rash. Valproic acid was reintroduced in one child and resulted in a second episode of pancreatitis. Resolution of symptoms usually took several weeks following discontinuation of the drug. No association was found with valproic acid dosage, type of preparation, serum levels, duration of therapy, or presence of concomitant medications. Pancreatitis is a severe adverse effect of valproic acid use in children. Dose, duration of treatment, serum valproic acid levels, generic preparation, and the presence of concomitant antiepileptic drugs do not appear to be risk factors. Children with known drug sensitivity might be at risk. Lipase levels at the time of an acute abdomen or a flulike illness in epileptic children taking valproic acid can reveal early stages of pancreatitis and are recommended.
More Related Videos
07:01Electrophoretic Delivery of γ-aminobutyric Acid (GABA) into Epileptic Focus Prevents Seizures in Mice
Published on: May 16, 2019
10:22Interictal High Frequency Oscillations Detected with Simultaneous Magnetoencephalography and Electroencephalography as Biomarker of Pediatric Epilepsy
Published on: December 6, 2016
Related Concept Videos
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Antiepileptic Drugs: Glutamate Antagonists
Acute Pancreatitis I: Introduction
Acute pancreatitis is characterized by rapid inflammation of the pancreas, often caused by factors like gallstone blockage or excessive alcohol consumption. Chronic pancreatitis, on the other hand, is a slow, progressive inflammation that may result from long-term alcohol abuse, obstructions in the pancreatic duct, or genetic factors.
The causes of acute pancreatitis include:
Acute Pancreatitis I: Introduction
Antiepileptic Drugs: GABAergic Pathway Potentiators
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
Chronic Pancreatitis II: Pathophysiology